SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today announced the appointment of Michael Buckner as chief legal officer, effective today. Buckner brings nearly three decades of experience as a senior global legal executive, with a proven track record of building and leading high-performing teams and deep expertise in complex transactions and regulatory environments. […]

TOKYO and NEWARK, Del. — ACROBiosystems, a company dedicated to being a cornerstone of the global biopharmaceutical and healthcare industries, announces its collaboration with Carterra, a company focused on innovative technologies designed to accelerate the discovery of novel therapeutic antibodies. Through the synergy of ACROBiosystems’ “FLAG” multi-pass transmembrane proteins and Carterra’s LSA platform, large-scale comprehensive characterization […]

BRANFORD, Conn. —  Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced that the company has successfully demonstrated sequencing on integrated Proteus™ instruments. This milestone was achieved using a developmental sequencing kit, the KinetIQ™ Array, and fully integrated Proteus instruments. The developmental sequencing kit […]

Expansion of Plainville, Mass., facility offers bioprocessing expertise, advanced technologies and customized support WALTHAM, Mass. — Thermo Fisher Scientific Inc., the world leader in serving science, today announced the opening of its flagship U.S. Bioprocess Design Center (BDC) at the company’s Plainville, Mass., site, expanding the facility to support customers in developing and scaling biologics. […]

SAN DIEGO — Singular Genomics Systems, Inc. today announced the appointment of John Stark as Chief Executive Officer. This leadership transition comes as Singular builds on the launch of its market-leading spatial platform and enters its next phase, focused on expanding adoption, deepening strategic partnerships, and increasing the impact of multimodal spatial data across translational research, drug development, and future […]

RADNOR, Pa. — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced that Ludovic Brellier will join the company as Executive Vice President, Bioscience & Medtech Products (BMP) & Chief Transformation Officer on May 1, 2026. In this role, […]

Orion HT and Orion LE extend the Orion platform from assay development through clinical trials, backed by an expanding biomarker reagent portfolio and commercial leadership focused on global growth SEATTLE — RareCyte®, a leader in precision biology products and technologies, today announced a significant expansion of its spatial proteomics portfolio with the commercial launch of […]

The Launch Early Access Program (LEAP) from Leica Microsystems provides supported access to the ATTOAuriga reagent platform Wetzlar, Germany –­ Leica Microsystems, a Danaher company and a leading provider of microscopy and scientific solutions, announced today that its Launch Early Access Program (LEAP) is now available, offering supported early access to ATTOAuriga, a novel spatial […]

Bioluminescence tools, companion diagnostics and automated sample preparation headline Promega presence at AACR 2026 MADISON, Wis. — Promega Corporation, a Madison, Wisconsin-based life science tools company, will present new technologies for cell health, target engagement and oncology diagnostics at the AACR Annual Meeting 2026 in San Diego, April 17-22. Researchers attending the conference can explore […]

ESPOO, Finland — New Finnish deep-tech company aims to make ultra-early disease detection possible through single-molecule protein amplification, enabling the identification of molecular warning signals long before disease becomes clinically visible. The technology has the potential to shift healthcare from reactive treatment to true prevention, extend healthy lifespans, and reduce the global burden of cancer, neurological disorders, and […]